# ğŸ§¬ COVID Digital Twin & Containment Simulation

A digital twin of an urban environment powered by AI agents and Reinforcement Learning to simulate, analyze, and optimize pandemic containment strategies.

---

## ğŸ¯ Objectives

- **Simulate Realistic Human Agents to Model Urban Dynamics**  
  Create human-like agents with lifelike demographics, routines, and behaviors that evolve over time, reflecting real-world social dynamics. This helps uncover patterns that drive smarter policy and resource planning during pandemics.

- **Train RL Agents for Disease Containment**  
  Utilize Reinforcement Learning to develop adaptive containment strategies (like dynamic lockdowns) that minimize disease spread while balancing economic and societal impacts.

---

## ğŸ§  Overview

This project combines **agent-based modeling** with **reinforcement learning** to build a **dynamic digital twin** of a city (modeled on Los Angeles). Each AI agent simulates real human behavior, allowing the system to evaluate and adapt containment strategies in response to pandemic scenarios.

---

## ğŸ”‘ Key Features

### ğŸ™ï¸ Digital Twin of a City

Simulates thousands of realistic human-like agents in a virtual city with detailed spatial geography and movement dynamics based on historical epidemic/pandemic data.

### ğŸ” Chain-of-Thought Driven Routines

Agents follow daily schedules generated using large language models to mimic diverse real-world behaviors and responses under epidemic conditions.

### ğŸ§ª RL-Based Policy Optimization

Custom OpenAI Gym environment enables RL agents to learn dynamic intervention policies (e.g., selective lockdowns) using algorithms like **Proximal Policy Optimization (PPO)**.

### ğŸ¥ Predictive Healthcare Insights

- Forecasts shortages in medical equipment, ICU beds, and medicine.
- Simulates the impact of travel restrictions and lockdowns on healthcare logistics.

### ğŸ§© Modular Architecture

- **Frontend:** Interactive dashboard (Next.js) with maps (Leaflet) and charts for visualization.
- **Backend:** Flask-based API hosting the simulation logic and chain-of-thought reasoning.
- **ML Module:** Scripts and environments for RL training using `stable-baselines3`.

---

## ğŸ§¬ How It Works

![Screenshot](./photos/architech.png)

### ğŸ”¹ Agent-Based Simulation

Each agent is initialized with a profile and dynamic routine. They interact, move, and influence infection dynamics across city neighborhoods.

### ğŸ”¹ Data-Driven Urban Modeling

Tracks time-series data like population density, infection rates, and economic loss. Enables realistic forecasting and planning.

### ğŸ”¹ Reinforcement Learning for Policy Optimization

Encapsulated in a custom Gym environment. The RL agent learns when and where to apply interventions to contain disease spread optimally.

### ğŸ”¹ Visualization & Insights

Real-time maps and dashboards show:

- Agent movements
- Infection spread
- Hospital resource predictions
- RL policy plans

---

## ğŸ–¥ï¸ Tech Stack

![Screenshot](./photos/tech.png)

---

## ğŸ“· Gallery

![Screenshot](./photos/gallery.gif)

---

## ğŸš€ Getting Started

### ğŸ”§ Prerequisites

- Node.js & npm
- Python 3.8+
- MongoDB

## ğŸ“ Directory Structure

```
HealthX/
  â”œâ”€â”€ backend/        # Flask app, simulation engine, RL environment
  â””â”€â”€ frontend/       # Next.js frontend with interactive maps & controls
```

---

### ğŸ› ï¸ Manual Setup

1. **Backend**

   ```bash
   cd HealthX/backend
   pip install -r requirements.txt
   python app.py
   ```

2. **Frontend**
   ```bash
   cd HealthX/frontend
   npm install
   npm run dev
   ```

---

## ğŸ“Š Sample Outputs

- ğŸ“Œ **Interactive Map:** Live city simulation with infection and economic overlays.
- ğŸ“ˆ **Containment Timeline:** RL-generated policy sequence (lockdowns/travel bans).
- ğŸ¥ **Hospital Insights:** Shortage forecasts and surplus indicators.
- ğŸ§  **Gemini Suggestions:** AI-generated recommendations for resource management.

---

## ğŸ“Œ Note

This project is a research-oriented prototype and not intended for real-world deployment without further clinical and epidemiological validation.
